Medical Technology 29 March 2026 - 17 May 2026

Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan
····

Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan

Mobia Medical shares traded lower on Monday morning, as the stroke-recovery device maker stayed under its IPO price less than a month after listing on the Nasdaq. The stock last traded at $12.84, off 26 cents from Friday’s close. It moved between $12.71 and $13.32 earlier in the session. Mobia is in its first run as a public company. The IPO put 10 million shares on sale at $15 apiece and aimed to bring in roughly $150 million before fees and other costs.
June 1, 2026
4DMedical Shares Move Higher Pre-Market With Test Ahead for 4DX
····

4DMedical Shares Move Higher Pre-Market With Test Ahead for 4DX

4DMedical Ltd will look to hold its rebound when trading opens Monday in Australia. The lung-imaging company finished at A$4.17 on Friday, gaining 8.88%. Volume reached around 13.6 million shares. Friday’s close marked a two-day recovery, but the stock is still down from its April highs. Why now: The ASX cash market is in pre-open in Sydney, and trading is expected to open as usual just before 10 a.m. local. ASX hasn’t listed May 18 among its 2026 cash-market holidays, so 4DX will trade like any regular Monday.
May 17, 2026
4DMedical Ltd Wins EU CE Mark, Raises A$83 Million as Mayo Clinic Deal Boosts CT:VQ Push
···

4DMedical Ltd Wins EU CE Mark, Raises A$83 Million as Mayo Clinic Deal Boosts CT:VQ Push

4DMedical disclosed in a Friday filing that its CT:VQ technology secured European Union CE mark certification. The Australian medtech also said it had raised A$83 million from institutional investors, a boost to fund its European ambitions. Shares ended the day at A$6.28, having hit A$7.55 earlier in the session. The timing comes into play as 4DMedical looks to build on recent U.S. hospital contracts and push for wider commercial uptake. According to the company, CT:VQ assesses how air and blood flow throughout the lungs using regular non-contrast CT scans—skipping the radiotracers needed for classic nuclear V/Q imaging.
March 29, 2026